En el marco del G20, se realizará un encuentro de neurociencias

Será el lunes y el martes en el hotel Hilton En el marco de la realización de la cumbre del G20 en la ciudad de Buenos Aires, en el hotel Hilton se llevará adelante una nueva edición del Neuroscience 20, un evento que se propone analizar el impacto económico que tienen las enfermedades del sistema nervioso. En total, se realizarán siete paneles de discusión en los que participarán distintos expertos del área de variadas nacionalidades. Además, habrá charlas y presentaciones de reconocidos profesionales. El lunes 26 se tratarán temas en cuatro paneles como la salud mental en general, la epilepsia, las enfermedades cardiovasculares y los desórdenes neurodegenerativos de la columna vertebral. El martes 27 los paneles de discusión girarán en torno a la neurooncología, las innovaciones en la neurocirugía y los traumas en el cerebro y la columna vertebral. En ese sentido, el presidente del comité local de Expertos del evento, Alejandro Mercado Santori, aseguró que las jornadas están basadas “específicamente en la esfera de las Neurociencias, y apuntado al análisis regional y global, tanto de la incidencia como así también del impacto económico que cada una de las enfermedades del sistema nervioso tienen en la población local y mundial”. “Estarán presentes neurocientíficos de gran prestigio y renombre, tanto del ámbito de la Neurología y Neurocirugía argentina, así como de distintas partes del mundo (Estados Unidos, Australia, Francia, Alemania, Brasil, Chile, México, India, entre otros), contando también con la presencia de investigadores internacionales del ámbito de la bio-ingeniería y de las telecomunicaciones”, agregó Mercado Santori. En esa línea, concluyó: “Esperamos acrecentar la estrecha relación entre ciencia, tecnología y política sanitaria. Creemos que es una oportunidad única para nuestro país, la cual no debemos dejar pasar por alto. Los ojos del mundo van a estar puestos en esta cumbre del G20″.

In the framework of the G20, a neurosciences meeting will be held

The G20, or Group of 20, is the main international forum for economic, financial and political cooperation En el marco de la realización de la cumbre del G20 en la ciudad de Buenos Aires, en el hotel Hilton se llevará adelante una nueva edición del Neuroscience 20, un evento que se propone analizar el impacto económico que tienen las enfermedades del sistema nervioso. En total, se realizarán siete paneles de discusión en los que participarán distintos expertos del área de variadas nacionalidades. Además, habrá charlas y presentaciones de reconocidos profesionales. El lunes 26 se tratarán temas en cuatro paneles como la salud mental en general, la epilepsia, las enfermedades cardiovasculares y los desórdenes neurodegenerativos de la columna vertebral. El martes 27 los paneles de discusión girarán en torno a la neurooncología, las innovaciones en la neurocirugía y los traumas en el cerebro y la columna vertebral. En ese sentido, el presidente del comité local de Expertos del evento, Alejandro Mercado Santori, aseguró que las jornadas están basadas “específicamente en la esfera de las Neurociencias, y apuntado al análisis regional y global, tanto de la incidencia como así también del impacto económico que cada una de las enfermedades del sistema nervioso tienen en la población local y mundial”. “Estarán presentes neurocientíficos de gran prestigio y renombre, tanto del ámbito de la Neurología y Neurocirugía argentina, así como de distintas partes del mundo (Estados Unidos, Australia, Francia, Alemania, Brasil, Chile, México, India, entre otros), contando también con la presencia de investigadores internacionales del ámbito de la bio-ingeniería y de las telecomunicaciones”, agregó Mercado Santori. En esa línea, concluyó: “Esperamos acrecentar la estrecha relación entre ciencia, tecnología y política sanitaria. Creemos que es una oportunidad única para nuestro país, la cual no debemos dejar pasar por alto. Los ojos del mundo van a estar puestos en esta cumbre del G20″.

Scientists Explain John McCain’s Brain Cancer

Scientists explain treatments for brain cancer and discuss glioblastoma, the brain cancer that took John McCain’s life. Christine Kim reports for NBC4 News at 11 p.m. on Aug. 26, 2018.

Brain Mapping Foundation Turned Los Angeles into the Brain Capital of the World and will be holding its first World BRAIN Expo in 2019 in Los Angeles

LOS ANGELES, April 23, 2018 /PRNewswire-USNewswire/ — 700+ World leading experts in brain/ spine mapping and therapeutics converged to Los Angeles last week at the 15th Annual World Congress of Society for Brain Mapping and Therapeutics (SBMT-April 13-15, 2018) in order to rapidly introduce new diagnostics and therapeutics for neurological disorders.  This year, the program had 11 keynote speakers including: Drs. Eric Kandel (Nobel Laureate), Deepak Chopra, Walter Copan (Undersecretary for Commerce), Jennifer Fogarty (Chief Scientist NASA Human Research Program), Carl Cotman (professor of Neurology UCI), Rear Admiral Riggs (Director of Research and Development-Defense Health Agency), Kyu Rhee (Chief Medical Office of IBM Watson Health), Jeremy Richman (Avielle Foundation), Warren Boling (SBMT President 2017-2018, Chair of Neurosurgery, LLU), Cartier Esham (Executive Vice President for Emerging Companies at the Biotechnology Innovation Organization (BIO), and Congressman Ted Lieu. “This year, we focused our program on innovation, translation, integration, and commercialization of neuro-technologies to advance therapeutics for our patients” said, Dr. Vicky Yamamoto, Executive Director of SBMT and a member of the Executive Board of BMF and SBMT, and a cancer scientist at the Department of Head and Neck Surgery at USC-Keck School of Medicine. The convention had 400 world-renowned scientists as invited speakers covering latest diagnostics and therapeutics platforms for Alzheimer’s disease, Parkinson’s disease, ALS, brain cancer, military medicine (PTSD, Traumatic Brain and Spine Injury, Chronic Traumatic Encephalopathy.…), gene therapy, neuro-vascular disorders, radiation oncology, NeuroEngineering, stroke, epilepsy, multimodality imaging, and spinal disorders including a practical cadaver lab supported by Globus Medical and Marksman Instrument.  UCLA Anderson School of Management faculty, George Abe, Professor and Director of the Strategic Management Research Program at UCLA Anderson School of Management and Tom Oser collaborated with Brain Mapping Foundation Brain Technology and Innovation Park (BTIP) and held series of sessions on Commercialization of Neuro-Technologies. “SBMT has made great impacts in the field scientifically not only through cross pollination of ideas and disciplines but also through enabling scientists to take their innovation to market.”  Dr. Tom Oser, Visiting Professor of Management of Technology & Innovation at UCLA Anderson School of Management. “SBMT is an unparalleled network of experts, entrepreneurs, non-profit and government segments, that all appear to be intent on accelerating the adoption of neuroscience solutions,” he continued. The Brain Technology & Innovation Park (BTIP) is aimed at fostering global partnership amongst biotechnology parks, NASA, US Federal and national labs, industry, academic institutions, non-profit and venture philanthropy organizations in order to rapidly introduce diagnostics and therapeutics for neurological disorders. The BTIP Initiative will be facilitating commercialization of neuro-technologies through necessary funded research and product development phases. Members of the BTIP could additionally participate in our various symposium and workshops at the annual meetings of SBMT in Los Angeles. “BMF is committed to make Los Angeles the capital of the world for brain and neurotechnology in general; we are honored to have such amazing luminaries as our keynotes and honored to award pioneers in the field including Drs. Kandel, Nikias, Federoff and Congressman Ted Lieu”, said, Dr. Babak Kateb, Chairman of the Board and CEO of SBMT, President of BMF and Director of Brain Technology and Innovation Park (BTIP).    Three screenings of an award-winning documentary on epilepsy, Brainstorm, were aired at the SBMT World Congress, and discussions were held on the topic by leading experts Drs. Warren Boling (LLU) and Dawn Eliashiv (UCLA).  The documentary was produced by Ms. Stacia Kalinowski who had documented her own struggle with epilepsy; this documentary was well received by epilepsy patients and their families and caregivers.  “SBMT is not only focused on advancing the science in the field but also insuring epilepsy patients access to the latest clinical trials and therapeutics available through our collaborating centers of excellence” Dr. Dawn Eliashiv, a member of the board of SBMT, Professor of Neurology and Co-director of the UCLA Seizure Disorder Center. SBMT’s slogan is “breaking boundaries of science, medicine, technology, art, and healthcare policy”.  This year, the foundation awarded many outstanding individuals including C. L. Max Nikias, USC President with Humanitarian Award for his global contributions to science, technology, art, and policy.  “I congratulate Dr. Max Nikias for this great honor, applaud and support amazing work done by the Brain Mapping Foundation including many of their initiatives” said Ming Hsieh, Founder and CEO of Fulgent Genetics, Inc., a member of the USC Board of Trustee and 2013 recipient of the BMF-SBMT Humanitarian award. The 2018 award winners were: USC President Dr. C. L. Max Nikias, recipient of the Humanitarian Award; Dr. Jeremy Richman, recipient of the Beacon of Courage and Dedication Award; Nobel Laureate Dr. Eric Richard Kandel, Former UCI Vice Chancellor Dr. Howard Federoff and Dr. Jonathan Kipnis, recipients of the Pioneer in Medicine Award; US Congressman Ted W. Lieu, recipient of the Pioneer in Healthcare Policy Award; United Neuroscience Co-founder Lou Reese, United Neuroscience Co-Founder Mei Mei Hu, United Neuroscience Co-Founder Dr. Chang Yi Wang and Dr. Bahram Jalali, recipients of the Pioneer in Technology Award; Dr. Warren Boling, recipient of the Golden Axon Leadership Award; and Drs. Dong Song and Wonhye Lee, recipients of the Young Investigator Award. “We continue to grow over the last 15 years and expand the outreach of the foundation beyond helping the wounded soldiers and veterans in order to impact soldiers, veterans and civilians with neurological disorders, spine disorders, and injuries, and they are critical to our mission,” said, Dr. Ken Green, Ret. US Navy Commander, Vice President of Brain Mapping Foundation, and a member of the executive board of SBMT. The 2018 event was supported by: Department of Commerce, Department of Defense, NIH, NASA/International Space Station, United Neuroscience, Bedside Viewer, Institute for Nerve Medicine/ Neurography, French Telethon, Eisai Pharmaceutical, Carl Zeiss Meditec Inc, IBM Watson Health, Medtronic Inc, Stryker, Globus Medical, Siemens, AML-Hong Kong, Olympus, Ad-Tech, Ricoh, Marksman, Fulgent Genetics, Neural Analytics and many more biotech and startups. 2019 World Brain and Spine Mapping and Therapeutics will be held at the LA Convention Center along with the world’s first World BRAIN EXPO on March 15-17th 2019. “2019 World Congress of Brain Mapping & Therapeutics will also include significant innovation in spine diagnostics and therapeutics” said, Dr. Jeffrey Wang, Co-director of USC Spine Center, Professor of Clinical Orthopedic Surgery and Neurosurgery (Clinical Scholar), and the 16th President of SBMT and a member of the Executive board of SBMT. About SBMT: www.WorldBrainMapping.Org About BMF: www.BrainMappingFoundation.Org Media Contacts: Dr. Ken Green Ken.Green@WorldBrainMapping.Org  202.577.5105 SOURCE Society for Brain Mapping and Therapeutics Related Links https://www.worldbrainmapping.org

Nikias honor reflects USC’s investment in brain mapping, bioscience

The university’s president receives the Humanitarian Award of the Society for Brain Mapping and Therapeutics USC President C. L. Max Nikias was honored April 14 with the Humanitarian Award of the Society for Brain Mapping and Therapeutics. The award is presented to physicians and scientists who have made significant contributions to survival and quality of life of patients across the globe. “It’s a tremendous honor to accept this award on behalf of the university,” said Nikias, emphasizing the priority USC has given to this important discipline. We have made significant investments and multidisciplinary appointments to advance our capabilities in brain mapping, neuroscience and the biosciences more broadly. C. L. Max Nikias “Because of the potential to improve the lives of so many people around the world, we have made significant investments and multidisciplinary appointments to advance our capabilities in brain mapping, neuroscience and the biosciences more broadly.” Leader in brain mapping USC has emerged as a leader in brain mapping, a field that straddles biological science and engineering and brings improved measurements to clinical treatments for diseases such as Alzheimer’s and autism. The field’s leading researchers like Paul Thompson and Arthur Toga make their home at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute and its Laboratory of Neuro Imaging. Among the researchers’ projects is the ENIGMA network, the largest brain-mapping project in the world. Harvard University radiologist and leading imaging expert Bruce Rosen once described Toga and Thompson’s group as “the world’s premier lab when it comes to finding insights about the brain in massive amounts of data from scans and genetic tests.” USC’s investment in the field also includes creating the Alzheimer’s Therapeutic Research Institute of the Keck School of Medicine of USC as leading Alzheimer’s researcher Paul Aisen came to the university. Aisen and his staff have enrolled more than 1,000 people in international clinical trials and are still seeking more participants. And in November, the university debuted Michelson Hall and the Michelson Center for Convergent Bioscience, a multidisciplinary center that brings scientists from all over the campus — the USC Dornsife College of Letters, Arts and Sciences, the USC Viterbi School of Engineering and the Keck School of Medicine — to solve the world’s most pressing health problems. Nikias receives award, praises USC’s priorities “This recognition is a testament to the advances USC has already made, and the trajectory the university is on, to be a global leader in these disciplines in the decades to come,” Nikias said. The Society for Brain Mapping and Therapeutics honors pioneers in brain mapping at its gala each year. This year’s event was held at the Millennium Biltmore hotel in Downtown Los Angeles. In addition to Nikias, the list of honorees included Nobel laureate Eric Kandel and U.S. Rep. Ted Lieu. “We have many university presidents and distinguished individuals who were nominated, but Dr. Nikias was the finest candidate because he is a Renaissance man who has impacted humanity through significant contributions to medicine, science, technology, art and policy,” said Babak Kateb, chairman and CEO of the Society for Brain Mapping and Therapeutics. “Our global strategy is to break the boundaries of science, technology, medicine, art and healthcare policy, and Max has clearly achieved that.” More stories about: Alzheimer’s Disease, Awards, Biotech, C. L. Max Nikias

LLU neurosurgery professor, chair honored with Golden Axon Award

Warren Boling, MD, professor of neurosurgery, chairman of the department of neurosurgery at Loma Linda University Health, has been honored with the 2018 Golden Axon Award, presented by the Society for Brain Mapping & Therapeutics and Brain Mapping Foundation. Each year, the organization awards various pioneers in the field of science, technology and medicine. The Society for Brain Mapping & Therapeutics is a non-profit biomedical association focused on brain mapping and intra-operative surgical planning. According to the society, brain mapping is defined as the study of the anatomy and function of the brain and spinal cord through the use of imaging, immunohistochemistry, molecular and optogenetics, stem cell and cellular biology, engineering, neurophysiology and nanotechnology. The Golden Axon Award was named for the neuron cell fiber that carries outgoing messages to other target cells. The award recognizes a highly regarded individual who helps raise awareness for the SBMT and its mission to serve the community. “The Society for Brain Mapping & Therapeutics is a unique and valuable organization that brings the highest level of scientists, researchers and clinicians together to collaborate and improve the care of our patients with neurological diseases,” Boling said. Boling also proudly serves as the new president of the Society of Brain Mapping & Therapeutics. The Golden Axon Award will be presented to Boling on Saturday, April 14 during the Brain Mapping Foundation Gala at the Millennium Biltmore Hotel in Los Angeles. 

LLU neurosurgeons urge congressional caucus to invest in neuroscience technologies

Two Loma Linda University (LLU) neurosurgeons said the economic impact of treating patients with neurological disorders is greater than treating other conditions — such as cancer and cardiovascular diseases — and that more investment in treatment and easing regulations could yield large benefits to both patients and society’s healthcare costs. Venkatraman Sadanand, MD, PhD, associate professor at LLU School of Medicine and attending pediatric neurosurgeon, and Daniel J. DiLorenzo, MD, PhD, MBA, assistant professor at LLU School of Medicine, made their remarks while presenting to the Congressional Neuroscience Caucus yesterday. The two were among six presenters at the 7th Annual Brain Mapping Day, held on Capitol Hill in Washington, D.C. this year in the Rayburn House Office Building. Sadanand and DiLorezno represented Loma Linda University Health during a twenty-minute presentation, highlighting the global burden of neurological disorders and the need to provide patients with the technologies that will help them return to the workforce. According to Sadanand, neurological disorders account for 13 percent of the globe’s economic impact of diseases, while cardiovascular accounts for 3 percent and cancer 10 percent. Sadanand said the annual cost to take care of patients with neurological disorders is approximately $400 billion and is expected to exceed one trillion over the next decade. Sadanand urged the caucus to reexamine how current dollars are allocated and to consider the following: “How do we incentivize our researchers to bring products to our patients?” According to Sadanand, the industry is increasingly working across companies to work collaboratively on discovering treatments for patients and the products they need to combat various diseases. “The problem is we are not able to bring the research to the patient at this time,” Sadanand said. The associate professor purposed the need for innovative approaches to therapeutics, including implementing a Brain Technology and Innovation Park. DiLorenzo approached the topic of neurosciences from an investment angle and the value of investing in new technologies that would reduce costs, increase regulatory efficiencies and improve outcomes for patients living with a neurological disorder. “Not only is it good for people, but good for the system because it’s the fiscally responsible thing to do,” DiLorenzo said. Among all other disorders, neurological disorders — including dementia, epilepsy, stroke and Parkinson’s disease — likely have the highest impact on the quality of life for patients and return on investment for treatment, DiLorenzo said. The goal is to take individuals with neurological disorders and return them back to work, while contributing to the system. “It’s a multi-dimensional return on investment, and that’s a common theme among neurological disorders,” DiLorenzo said. This was the first time both Sadanand and DiLorenzo attended the Annual Brain Mapping Day. Throughout the event, the two met with various representatives to continue the conversation on neuroscience technologies. Both professors plan to maintain contact with members of the caucus and continue to educate and lead theway in new research and technologies for improving neurological disorders.

Global unity and alliance Brain Mapping and Therapeutics will be achieved in Germany during the G20 Summit at 4th Annual G20 BRAIN Initiative/Neuroscience-20 summit

Los Angeles, CA, Fraunhofer IME, Uskudar University , the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation (BMF), National Center for NanoBioElectronic (NCNBE) have come together in Hamburg, Germany during the G20 Summit to expand global cooperation and partnership on clinical translational neuroscience through Neuroscience-20 (N20) Initiative. The scientists call for global collaboration, partnership, data-sharing, and more allocation of funds to combat enormous economical and human costs of neurological disorders world wide “Neuroscience-20 Initiative of SBMT is a truly impressive approach toward building global consortia of Brain Initiatives in order to create a united front for tackling devastating neuro-psychiatric disorders worldwide,” said Professor Carsten Claussen, Director of the Fraunhofer Institute for Molecular Biology and Applied Ecology IME, division ScreeningPort in Hamburg, a member of SBMT and Vice-Chairman of the 4th Annual N20 in Hamburg Germany. On July 5th 2017, world’s leading physicians, engineers, neurosurgeons, basic and clinical scientists are gathering at the 4th Annual N20 at the Empire Riverside Hotel, Hamburg, Germany. “Uskudar University is truly honored to jointly sponsor this remarkable gathering of global thought-leaders in Germany; we are looking forward to building multilateral partnership with scientists worldwide through N20” Said Professor Nevzat Tarhan, President of Uskudar University, President of SBMT-Turkey and Vice-Chairman of the N20. The 4th annual N20 program covers all aspects of brain mapping and therapeutics from imaging, connectomics, mathematical modeling, and artificial intelligence to nanoneuroscience, neurophotonics and genomics. The program is aimed at exchanging scientific progress across disciplines of science and technology, which could enable scientists to rapidly introduce new diagnostics and therapeutics. “The human and financial cost of the neurological disorders to the world is enormous; the cost of care of near 5.5 million Alzheimer’s patients in the US alone is now close to $200 billion annually; this cost will be closer to $1 trillion in 10 years,” said Dr. Babak Kateb, Founding Chairman of the Board and Scientific Director of SBMT, President of BMF, Director of NCNBE and Director of Brain Technology and Innovation Park (BTIP), “in 2015, the cost of dementia to the world economy was $818 million which corresponds to the care for near 46.8 million patients; in 2030, this cost will be $2 trillion for dementia alone; this means if dementia was a country, it would be number 18 on the Gross Domestic Product (GDP)”. SBMT has been on the forefront of establishing global Brain Initiatives in the last 15 years and was a key player in formulating and supporting Obama’s BRAIN Initiative. Scientific delegations across the G20 will be attending the symposium; the registration for N20 summit will be closed on July 4th 2017. For more details about the program, you can contact Vice President of Brain Mapping Foundation, Ret. Navy Commander Dr. Ken Green at Ken.Green@WorldBrainMapping.Org

Global unity and alliance in Brain Mapping and Therapeutics will be achieved in Germany during the G20 Summit at 4th Annual G20 BRAIN Initiative/Neuroscience-20 symposium

LOS ANGELES, June 27, 2017 /PRNewswire-USNewswire/ — Fraunhofer IME Institute, Uskudar University , the Society for Brain Mapping and Therapeutics (SBMT), Brain Mapping Foundation (BMF), National Center for NanoBioElectronic (NCNBE) have come together in Hamburg, Germany during the G20 Summit to expand global cooperation and partnership on clinical translational neuroscience through Neuroscience-20 (N20) Initiative. “Neuroscience-20 Initiative of SBMT is truly impressive approach toward building global consortia of Brain Initiatives in order to create a united front for tackling devastating neuro-psychiatric disorders worldwide,” said Professor Carsten Claussen, Director of Fraunhofer Institute in Hamburg, a member of SBMT and Vice-Chairman of the 4th Annual N20 in Hamburg Germany. On July 5th 2017, world’s leading physicians, engineers, neurosurgeons, basic and clinical scientists are gathering at the 4th Annual N20 at the Empire Riverside Hotel, Hamburg, Germany. “Uskudar University is truly honored to jointly sponsor this remarkable gathering of global thought-leaders in Germany; we are looking forward to building multilateral partnership with scientists worldwide through N20” Said Professor Nevzat Tarhan, President of Uskudar University, President of SBMT-Turkey and Vice-Chairman of the N20. The 4th annual N20 program covers all aspects of brain mapping and therapeutics from imaging, connectomics, mathematical modeling, and artificial intelligence to nanoneuroscience, neurophotonics and genomics. The program is aimed at exchanging scientific progress across disciplines of science and technology, which could enable scientists rapidly introduce new diagnostics and therapeutics. “The human and financial cost of the neurological disorders to the world is enormous; the cost of care of near 5.5 million Alzheimer’s patients in the US alone is now close to $200 billion annually; this cost will be closer to $1 trillion in 10 years.” said, Dr. Babak Kateb, Founding Chairman of the Board and Scientific Director of SBMT, President of BMF, Director of NCNBE and Director of Brain Technology and Innovation Park (BTIP)  “in 2015, the cost of dementia to the world economy was $818 million which corresponds to the care for near 46.8 million patients; in 2030, this cost will be $2 trillion for dementia alone; this means if dementia was a country, it would be number 18 on the Gross Domestic Product (GDP)”. SBMT has been on the forefront of establishing global Brain Initiatives in the last 15 years and was a key player in formulating and supporting Obama’s BRAIN Initiative. Scientific delegations across the G20 will be attending the symposium; the registration for N20 summit will be closed on July 4th 2017. For more details about the program, you can contact Vice President of Brain Mapping Foundation, Ret. Navy Commander Dr. Ken Green at Ken.Green@WorldBrainMapping.Org USA Media Contact:Dr. Ken GreenKen.Green@WorldBrainMapping.Org 202 577-5105 Turkish Media Contact:Öznur Özcan Yıldırımoznur.ozcanyildirim@uskudareurope.com +491746001979 German Media Contact:Dr. Mira GraettingerMira.graettinger@ime.fraunhofer.de +49 (40) 303764-270 About SBMT:www.WorldBrainMapping.Org About BMF:www.BrainMappingFoundation.Org About Uskudar University:http://www.uskudar.edu.tr/en About Fraunhofer Institute for Molecular Biology and Applied Ecology IME:https://www.ime.fraunhofer.de/en.html SOURCE Society for Brain Mapping and Therapeutics Related Links http://www.WorldBrainMapping.Org

G20 HAMBURG 2017

4th Annual G20 World Brain Mapping Summit Wednesday July 5th 2017 PROGRAM Symposium ProgramWednesday, July 5th 2017 07:00-08:00 AM Registration and Breakfast-First Floor 08:00-10:00 AM Press and Media coverage 10:00-10:10 AM Carsten Claussen, PhDLocal Organizing Chair of N20, Director Fraunhofer IME ScreeningPort, Professor for Informatics Heinz Nixdorf Institute PaderbornWelcoming Message 10:10-10:20 AM Babak Kateb, M.D.President and Professor of Psychiatry Uskadar University, Istanbul, Turkey; Vice Chairman of Neuroscience-20+, Member of the Board of SBMTTurkish N20+ Initiative (Update) 10:30-10:40 AM Kuldip Sidhu, PhDProfessor of Stem Cell, University of New South Wells (UNSW), Sydney Australia, Vice-Chairman of Neuroscience-20+, Member of the Executive Board of SBMT, Member of the Board of Brain Mapping Foundation USA; President of Brain Mapping Foundation-AustraliaNew frontiers in tackling brain disorders – an Australian perspective for G20/N20 10:40-11:10 AM Coffee Break Scientific Session 1: (Chair: Dr. Carsten Claussen) 11:10-11:20 AM Siawoosh Mohammadi, PhDMedical Center Hamburg-Eppendorf UKE, Center for Experimental MedicineQuantitative MRI and in vivo histology 11:20-11:30 AM Benjamin Schattling, PhDCenter for Molecular Neurobiology Hamburg (ZMNH)Cellular mechanisms of neuronal injury and repair 11:30-11:40 AM Ole Pless, PhDFraunhofer IME ScreeningPort, Head translational science and lab head ZMNHiPs derived neurons as tool for drug discovery 11:40-11:50 AM Christina de Bruyn Kops MScCenter for Bioinformatics University of Hamburg, Research Group for Cheminformatics and Applied Molecular Models.Novel computational approaches for early drug discovery 11:50-12:00 PM Q/A Working Lunch 12:10-12:40 PM Luncheon KeynoteProf. Arne May, MDMedical Center Hamburg-Eppendorf UKE Center for Experimental Medicine, Deputy Director of the Institute of Systems Neuroscience, Head of headache outpatient clinicImaging Migraine from generators to networks Scientific Session 2: (Chair: Dr. Nevzat Tarhan) 1:30-1:40 PM Nevzat Tarhan, MDPresident of Uskadar University, Professor and Chair of Psychiatry, Uskadar University, Istanbul, TurkeyThe future of psychiatric neuroscience 1:40-1:50 PM Baris Metin, MDAssociate Professor of Psychaietry, Uskadar University, Istanbul TurkeyBrainpark, Business Incubator for neurotechnology startups 1:50-2:00 PM Serdar Karagoz, MSc, PhDAdministrative Director, Office of the President, Uskadar University, Istanbul, TurkeyBrain Hospital of the Future concepts 2:00-2:10 PM Kaya Aksoy, MDProfessor of Neurosurgery, Uskadar University, Istanbul, TurkeyNeurosurgical concept in the Brain Hospital 2:10-2:20 PM Q/A 2:20-2:30 PM Break Scientific Session 3: (Chair: Dr. Ken Green) 3:00-4:00 PM Dr. Ken Green, MDVP of Brain Mapping Foundation and Member of the Executive board of SBMT 3:00-3:10 PM Mike Roy, MD, MPHMember of the Board of SBMT, Past President of SBMT, Professor of Internal Medicine, Uniformed Services University Health System (USUHS), Ret. Colonel, United Stated Army, Washington DC, USASingle and Multiple Traumatic Brain Injuries, Posttraumatic Stress Symptoms, and Cognitive Performance in Military Service Members 3:10-3:20 PM Antonio A.F. De Salles, M.D., PhDProfessor Emeritus of Neurosurgery – UCLA, Departments of Neurosurgery and Radiation Oncology, USA, Head HCor Neuroscience, Brazil, President of the Ibero-Latin American Radiosurgery Society, President of the International Stereotactic Radiosurgery Society (ISRS), Vice Chairman of N20/G20 World Brain Mapping Initiative-Brazil, President of SBMT-BrazilNeuromodulation in Depression and Morbid Obesity 3:20 -3:30 PM Babak Kateb, M.D.Neuroscience-20+/G20+ World Brain Mapping Initiative Chairman, Founding Chairman of the Board of SBMT, President of BMF, Scientific Director of California Neurosurgical InstituteNanoBioElectronics: Integrating nanotechnology, stem cell, AI, Imaging and Neurophotonics 3:30-3:40 PM Vicky Yamamoto, PhDCancer Scientist, Department of Head and Neck Surgery, USC-Keck School of Medicine, Member of the Executive Board of SBMT, Member of the Board of Brain Mapping Foundation and Executive Director of SBMT, USACancer Moonshot: Past, Current and the Future state-of-the-science 3:40-3:50 PM TBD 3:50-4:00 PM Q/A 4:00-4:30 PM Break 4:30-5:00 PM Keynote 2Prof. Dr. Martin Hofmann-ApitiusFraunhofer Institute for Algorithms and Scientific Computing SCAI, Head of Bioinformatics. Professor of Applied Life Science University BonnThe modelling of neurodegenerative diseases 5:00-5:10 PM Q/A 5:10-5:20 PM Break 5:20-6:00 PM Roundtable discussion and summit conclusionCo-Chair: Nevzat Tarhan, Babak Kateb, Carsten Claussen, Kuldip Sidhu